Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederstatnews.com
STAT
Get the latest updates from STAT directly as they happen.
Follow now 229 followers
Latest posts
Last updated less than a minute ago
Senior NIH scientist, research fellow charged with bringing deactivated mpox virus into U.S.
1 minute ago
DETROIT — Two scientists at a U.S. government lab were charged with...
STAT+: Longevity startup NewLimit raises $435 million ahead of first clinical trial
about 8 hours ago
Longevity startup NewLimit plans to launch its first clinical trial of a...
STAT+: Radiopharmaceutical shows promise in post-Pluvicto setting
about 10 hours ago
Want to stay on top of the science and politics driving biotech...
STAT+: Pharmalittle: We’re reading about a Lilly threat to 340B hospitals, Ebola vaccine funding, and more
about 11 hours ago
Rise and shine, everyone, another busy day is on the way. And...
How one state’s medical meal program lowered health care costs
about 12 hours ago
Get your daily dose of health and medicine every weekday with STAT’s...
STAT+: Online care is caught in the crossfire as states crack down on corporate medicine
about 16 hours ago
In less than a decade, telehealth has expanded from a sideshow of...
Opinion: The virtual end of the doctor’s office waiting room
about 16 hours ago
The word patient comes from the Latin patiens — an adjective meaning...
STAT+: Trump administration releases rules for new Medicaid work requirements
1 day ago
WASHINGTON — The Trump administration on Monday published a highly anticipated document...
STAT+: Eli Lilly warns hospitals to submit claims data in the next five days or lose their 340B drug discounts
1 day ago
Eli Lilly has told more than 1,000 hospitals participating in a federal...
STAT+: Global coalition to fast-track 3 vaccines targeting Ebola outbreak with $62 million in funding
1 day ago
With no licensed vaccines available to protect against the Ebola virus currently...
STAT+: Abivax ulcerative colitis drug shows strong efficacy, but cases of cancer raise concerns
1 day ago
Abivax said Monday that its experimental treatment for ulcerative colitis showed significant...
STAT+: At ASCO, talk of barriers to cancer care, new treatments, and other big takeaways
1 day ago
We asked Brian Wolpin, the presenter for yesterday’s plenary on the daraxonrasib...